Floatz logo

Therapeutic Asset Ratings

136 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
9mw2821
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
Acetylsalicylic Acid
HER2-negative Breast Cancer
The Methodist Hospital Research InstituteP2CCC (48)
Adebelimab
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
AMLODIPINE
HER2-negative Breast Cancer
The Methodist Hospital Research InstituteP2CCC (48)
arx788
HER2-negative Breast Cancer
QuantumLeap Healthcare CollaborativeP2CCC (48)
ARX 788
HER2-negative Breast Cancer
QuantumLeap Healthcare CollaborativeP2CCC (48)
Benmelstobart
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
DALPICICLIB ISETIONATE
HER2-negative Breast Cancer
Peking University People's HospitalP2CCC (48)
Datopotamab Deruxtecan
HER2-negative Breast Cancer
Ana C Garrido-Castro, MDP2CCC (48)
Dostarlimab
HER2-negative Breast Cancer
Dana-Farber Cancer InstituteP2CCC (48)
Encequidar
HER2-negative Breast Cancer
QuantumLeap Healthcare CollaborativeP2CCC (48)
Fianlimab
HER2-negative Breast Cancer
QuantumLeap Healthcare CollaborativeP2CCC (48)
FLUOROURACILUM
HER2-negative Breast Cancer
Guangdong Provincial People's HospitalP2CCC (48)
Gsk 5733584
HER2-negative Breast Cancer
QuantumLeap Healthcare CollaborativeP2CCC (48)
hb1801
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
Hrs-1167
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
Hrs-4508
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
Hrs-6209
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
ibi354
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
HER2-negative Breast Cancer
QuantumLeap Healthcare CollaborativeP2CCC (48)
Ivonescimab
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
js207
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
Jskn003
HER2-negative Breast Cancer
Fudan UniversityP2CCC (48)
Ladiratuzumab Vedotin
HER2-negative Breast Cancer
QuantumLeap Healthcare CollaborativeP2CCC (48)
Lasofoxifene
HER2-negative Breast Cancer
QuantumLeap Healthcare CollaborativeP2CCC (48)
Showing 51 to 75 of 136 assets
PreviousPage 3 of 6Next